Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data.
about
Management strategies in the treatment of neonatal and pediatric gastroenteritisInternational society for disease surveillance conference 2011: building the future of public health surveillanceImpact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed dataEpidemiology, Seasonality and Factors Associated with Rotavirus Infection among Children with Moderate-to-Severe Diarrhea in Rural Western Kenya, 2008-2012: The Global Enteric Multicenter Study (GEMS)Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic modelsEffectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.Health gains and financial risk protection: an extended cost-effectiveness analysis of treatment and prevention of diarrhoea in EthiopiaFull-Genome Sequence of the First G8P[14] Rotavirus Strain Detected in the United States.Cost effectiveness of infant vaccination for rotavirus in CanadaDetermining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs.Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011Norovirus and medically attended gastroenteritis in U.S. childrenProtective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children.Hospitalizations for intussusception before and after the reintroduction of rotavirus vaccine in the United States.The first rotavirus vaccine and the politics of acceptable risk.Effectiveness of Rotavirus Vaccination: A systematic review of the first decade of global post-licensure data, 2006-2016.New insights into rotavirus vaccines.Group A rotaviruses in children with gastroenteritis in a Canadian pediatric hospital: The prevaccine eraFull genome characterization of the first G3P[24] rotavirus strain detected in humans provides evidence of interspecies reassortment and mutational saturation in the VP7 geneClinical and cost burden of rotavirus infection before and after introduction of rotavirus vaccines among commercially and Medicaid insured children in the United StatesValidation of the modified Vesikari score in children with gastroenteritis in 5 US emergency departmentsSustained Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Children.Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013.Dynamic modeling of cost-effectiveness of rotavirus vaccination, Kazakhstan.Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010.Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial.Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.Rotavirus vaccine: a cost effective control measure for India.Intussusception following rotavirus vaccination: an updated review of the available evidence.Molecular epidemiology of norovirus in children and the elderly in Atlanta, Georgia, United States.Global Impact of Rotavirus Vaccination on Childhood Hospitalizations and Mortality from Diarrhea.Comparison of three multiplex gastrointestinal platforms for the detection of gastroenteritis viruses.Assessing the impacts of the first year of rotavirus vaccination in the United Kingdom.Clinical characteristics and outcome in norovirus gastroenteritis.Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013.Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options.Assessing the Likely Impact of a Rotavirus Vaccination Program in England: The Contribution of Syndromic Surveillance.Pediatric norovirus infection.Norovirus infection in immunocompromised children and children with hospital-acquired acute gastroenteritis.
P2860
Q27004496-B4108419-5FDA-483F-A459-54E354670DE9Q28732714-C1B1B8CC-9CDD-46C2-8AE6-0804D72FD19AQ30000818-F2AF4C4D-C7F1-435F-B01A-7CA922FB3BC9Q30276185-9D7F9D66-5406-4125-B27B-D7518ABDE697Q31086859-BF19CE35-E375-4C18-8390-FC1AA710ED94Q35217987-80842C78-B250-4D9F-9402-1D5FEBB4B357Q35573097-41BFD33F-B815-42B3-B71C-3452C8027696Q35757013-21B8DD41-7B80-43F1-BF35-51DF24695DFFQ36111776-150D6589-512D-41E5-B76B-9E5B1D35DC95Q36201298-71C61404-B9F4-4E5A-AD7F-40D9DDEC4076Q36201304-0A9764E7-D296-476C-90F5-4B744BD027E5Q36201314-78581101-645A-4742-B7C9-51AC0E5D1B60Q36201344-2A2AFEC7-49A9-42E6-8792-E7C48B2B8F4AQ36235204-68765EB2-C7CD-4766-9755-BAE2719AE7FEQ36285460-7E0DB150-A5AF-4D0D-BFEC-DEF4DF765578Q36356363-C492C567-7261-490A-93BD-93D6AA938DAAQ36552854-F52A9FBA-F057-4544-80A1-9A3D18ED2D24Q36777543-F3795BD6-D0E2-4F34-A792-E2F0F593088CQ36785330-65CDD8DB-4192-4D4E-B7D4-15F41018DE8CQ36978372-EA3B535E-52A5-4A3E-BE4D-FFAF834EFCD7Q37211315-0D08F18B-9439-4E92-BF34-115485242751Q37292341-EB4159D2-A473-4825-825D-6A17E6E3DFA9Q37360508-E6491168-B49E-49AA-97D8-39D6ED84A76BQ37448980-46269524-E67C-46A6-8E83-A812B5431C6AQ37671911-4011425D-2083-4EB2-A848-FA03C95DCB61Q37695264-7602B420-B6F7-427F-A7D1-200A8DE29C31Q37866754-4E32A91D-4F2E-4F52-BC52-21D9392E4881Q37944318-4B0199F2-B691-42FB-A4B3-D8650F4F1A96Q38052557-B897B3F4-455B-4654-BBEB-279C936E8812Q38234440-C1CBF1F8-B75F-4C57-808D-C176A5F59E53Q38645513-1244A985-8B62-4A41-8AE4-B2E68C2BDBC6Q38826540-6A710A7D-9FBC-4584-AF8A-B835C1EDD603Q40049174-558573FD-1F24-416A-8400-9DA0DA7F15F2Q40203920-4806A1BC-7A6D-44B0-8FB1-B2A5A319DBDEQ40211472-09654F76-A2CD-432B-99DB-73CC5DA4865CQ40451693-43904F52-1274-4543-8CEF-9B57CF2896AEQ40485965-CB5D1860-0F92-41AC-96B4-5A59E5E684AEQ41131578-1553109B-8EF4-429A-81CC-D2DFD6B37611Q42247731-908EE816-73D8-4BBE-B6D6-C16DEBC3BB77Q42263362-74CB3F9B-C2A9-4C8E-BC30-16C3B5247340
P2860
Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Uptake, impact, and effectiven ...... 3 years of postlicensure data.
@ast
Uptake, impact, and effectiven ...... 3 years of postlicensure data.
@en
type
label
Uptake, impact, and effectiven ...... 3 years of postlicensure data.
@ast
Uptake, impact, and effectiven ...... 3 years of postlicensure data.
@en
prefLabel
Uptake, impact, and effectiven ...... 3 years of postlicensure data.
@ast
Uptake, impact, and effectiven ...... 3 years of postlicensure data.
@en
P2093
P50
P1476
Uptake, impact, and effectiven ...... 3 years of postlicensure data.
@en
P2093
Aaron T Curns
Catherine Yen
Daniel C Payne
Douglas H Esposito
Jennifer E Cortes
Jon R Gentsch
Manish M Patel
Margaret M Cortese
P304
P356
10.1097/INF.0B013E3181FEFDC0
P433
P577
2011-01-01T00:00:00Z